Respiratory therapeutic devices are used in the treatment, management, and control of cardiopulmonary diseases such as chronic obstructive pulmonary diseases (COPD), asthma, acute bronchitis, cystic fibrosis, and others.

Respiratory therapeutic devices market CAGR is expected to be 9.50% during the forecast period and the market size is expected to reach nearly US$ 28.58 Bn. by 2029.